C
Cogent Biosciences, Inc. (COGT)
NMS – Real Time Price. Currency in USD
34.53
+0.43 (1.26%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
34.53
+0.43 (1.26%)
At close: May 12, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $241.2M significantly exceed its total debt $238.7M, ensuring strong financial flexibility
Total current assets $877.8M exceed Total current liabilities $58.0M, highlighting excellent liquidity
Debt-to-equity ratio (0.4) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-85.4x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$87.3M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 15.14 | 6.05 | 10 | |
| Quick ratio | 15.14 | 5.63 | 10 | |
| Debt to Equity | 0.39 | 0.30 | 7.0 | |
| Debt to Assets | 0.26 | 1.04 | 7.0 | |
| Interest coverage | -85.41 | -16.91 | 1.0 | |
| Weighted average score | 7.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -6M | -4M | -4M | -5M | -5M |
| Operating Income | -148M | -208M | -276M | -333M | -362M |
| Net Income | -140M | -192M | -256M | -329M | -354M |
| EBITDA | -142M | -205M | -272M | -329M | -357M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -4.71 | 1.0 |
| Next quarter | N/A | -14.45 | 1.0 |
| Current year | N/A | -3.86 | 1.0 |
| Next year | 3001.45 | 65.71 | 10 |
| Weighted average score | 3.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 5.02 | 12.4 | -9.27 | 5.8 |
| Y/Y | 999 | -35.23 | 16.58 | -30.22 | 5.3 |
| 3y average | 999 | -32.89 | 3.1 | -28.48 | 4.0 |
| 5y average | 779.2 | -37.86 | 13.99 | -52.32 | 5.0 |
| Weighted average score | 5.0 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |